x

    Request a Callback

    Fill in your details and our team will get in touch with you.


    Genomic Profiling of Rapidly Dedifferentiating MSI-HighEndometrial Carcinoma

    More Author(s)

    64y Female diagnosed with Grade 3 Endometrioid adenocarcinoma; history of left axillary lump
    • Initial Treatment: Underwent total uterine hysterectomy
    • Further evaluation: Molecular profiling via OncoIndx 360 Tissue Biopsy to understand progression & identify 
    actionable therapeutic targets 
    Clinical Challenges
    • Rapid progression to metastatic undifferentiated carcinoma with new abdominal mass, complicating primary site confirmation 
    and treatment planning.

    Related Articles

    1Cell.Ai
    Privacy Overview

    This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.